CSTL Q4 2019 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$18M+54.2% YoY

Gross Profit

$16M88.6% margin

Operating Income

$3M14.8% margin

Net Income

$2M11.7% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+19.4%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$120M

Total Liabilities

$35M

Stockholders' Equity

$85M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$11M	+54.2%
Gross Profit	$16M	$10M	+55.2%
Operating Income	$3M	$5M	-45.2%
Net Income	$2M	$4M	-46.9%